A1J84E
AbbVie, Inc. · LS:A1J84E
262.30 EUR−1.30 −0.49%
AbbVie, Inc. (LS:A1J84E) last traded at 262.30 EUR, down 0.49% on the day. Over the past year the stock is up 33.28%. Its 52-week range is 164.20 to 265.60. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open263.20
Day range262.30 – 263.60
52-week range164.20 – 265.60
Volume54
Average volume (10 days)44
Market cap (USD)521.11 B
P/E51.07
EPS (TTM) (USD)5.82
Dividend yield2.35%
Beta (1 year)0.0129
Revenue (TTM) (USD)66.01 B
Employees57.00 K
Performance
+3.63%1 week
+13.85%1 month
+23.55%3 months
+49.08%6 months
+35.63%Year to date
+33.28%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- AbbVie Price Target Raised to $322.00/Share From $288.00 by GuggenheimDow Jones Newswires · 02 Nov 2026
- Guggenheim maintains AbbVie at Buy, raises price target to $322 from $288TradingView · 02 Nov 2026
- Brise Pharmaceuticals Announces Global License Agreement With Abbvie To Advance The Next-Generation Of Migraine TherapiesReuters · 02 Nov 2026
- AbbVie Price Target Raised to $340.00/Share From $300.00 by Wells FargoDow Jones Newswires · 02 Nov 2026
- Wells Fargo maintains AbbVie at Overweight, raises price target to $340 from $300TradingView · 02 Nov 2026
- AbbVie Price Target Raised to $330.00/Share From $280.00 by RBC CapitalDow Jones Newswires · 02 Nov 2026
- RBC Capital maintains AbbVie at Outperform, raises price target to $330 from $280TradingView · 02 Nov 2026
- AbbVie Is Maintained at Buy by Canaccord GenuityDow Jones Newswires · 02 Nov 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.